• Pfizer's anti-viral 3CL protease inhibitor shows antiviral potential against SARS-CoV-2

    11 days ago - By News Medical

    Now, a new study by researchers from Pfizer, University of Arizona, Purdue University, The Scripps Research Institute, and UC San Diego School of Medicine and published on the preprint server bioRxiv in September 2020 reports that an enzyme inhibitor may act in synergism with the approved antiviral remdesivir to suppress viral replication in COVID-19.
    Read more ...

     

  • Arizona COVID-19 Genomics Union tracks SARS-CoV-2 genome sequences

    11 days ago - By News Medical

    Initial findings reported by the Arizona COVID-19 Genomics Union suggest that following Arizona's first reported case of COVID-19 in late January, the state experienced no cases that went undetected and was COVID-free until at least 11 distinct incursions occurred between mid-February and early April.
    Read more ...